Telemedicine company SnapMD rakes in $7.1M to bolster sales and marketing efforts
The California company also plans to innovate its product, help its clients manage their virtual care programs and engage the broader market.
The California company also plans to innovate its product, help its clients manage their virtual care programs and engage the broader market.
Through the collaboration, Baird will be mentoring and investing in startups in the TMCx accelerator, as well as setting up its Houston office right in the Texas Medical Center.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The two health insurance giants and firm Health Velocity Capital led the round for the Sunrise, Florida organization. Novo Holdings A/S and Industry Ventures also participated.
Investment could be called frothy, but hasn't reached bubble territory yet, SVB report author says.
The population health startup will use the funding to foster additional engagement with consumers, expand its access points and advance collaboration with healthcare delivery systems.
The most recent MoneyTree report from PwC and CB Insights highlights the biggest biotech-related and medical devices VC deals in Q2, which include investments in companies like Grail, Allogene Therapeutics, RefleXion Medical and Mevion Medical Systems.
Healthcare Growth Partners has released two of the questions and responses from its biannual health IT M&A survey. The queries asked respondents about the regulatory impact of the Trump administration on their company, as well as whether they think health IT is in a "bubble."
Gates will invest $50 million in the Dementia Discovery Fund. This will be followed by another $50 million investment in startups working on Alzheimer's research.
Disorderly books cause potential investors to lock up their wallets and throw away the key. It's not just because it looks unprofessional; it’s because every piece of a business is entwined with finances.
Despite reimbursement, regulatory, and political uncertainty, the global biotech industry held steady in 2016, according to a new report by professional services firm EY (formerly Ernst & Young).
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
With a $7 million Series A financing round, ApoGen has become the latest startup to enter Accelerator Corporation's syndicate funding and operational support program. It's a strong endorsement from a firm which makes very few investments.
These issues are a critical part of the national conversation on healthcare funding — funding which advances cures, drives economic growth and spurs technological innovation.
In a joint press release, NantHealth and Allscripts said that they would jointly integrate their software via application provider interfaces
Life sciences startups are guilty of having unduly complicated investment pitches. Ease up on the angel investors. Make your science easy to understand.
Rosemark Capital founder talks about the company's interest in population health investments.